histamine has been researched along with Dermatitis in 81 studies
Dermatitis: Any inflammation of the skin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Histamine is an inflammation mediator that is fundamental for the development of some allergic reactions and is also implied in several common dermatological affections." | 4.82 | [Anti-H1 in dermatological practice]. ( Gaudy-Marqueste, C; Grob, JJ; Richard, MA, 2005) |
| "We examined the effect of topical thymol on IgE-dependent responses using a mast cell-dependent passive cutaneous anaphylaxis (PCA) model, as well as in vitro-cultured mast cells." | 3.80 | IgE-mediated mast cell responses are inhibited by thymol-mediated, activation-induced cell death in skin inflammation. ( Bryce, PJ; Hsu, CL; Wechsler, JB, 2014) |
| "In vivo antihistaminic activity experiments consisted of measurement of: inhibition of increase in capillary permeability and reduction in microvascular extravasation and bronchospasm in rats and guinea pigs induced by histamine and other inflammatory mediators; and protection against lethality induced by histamine and other inflammatory mediators in rats." | 3.73 | In vivo pharmacological characterisation of bilastine, a potent and selective histamine H1 receptor antagonist. ( Berisa, A; Corcóstegui, R; Innerárity, A; Labeaga, L; Orjales, A, 2006) |
| "To clarify the mechanisms for the dermal mast cell hyperplasia in NC, we prepared bone marrow-derived mast cells (BMMCs) from three strains of mice, NC/Kuj, C57BL/6 and BALB/c, and compare histamine contents, histamine release abilities, adhesive properties and apoptosis of the BMMCs." | 3.70 | Altered in vitro apoptosis of cultured mast cells prepared from an inbred strain of mice, NC/Kuj. ( Hiragun, T; Kameyoshi, Y; Kanno, M; Morita, E; Okabe, T; Shindo, H; Tanaka, T; Yamamoto, S, 2000) |
| "Interstitial fluid pressure (Pif) was measured in skin of pentobarbital-anesthetized rats during anaphylaxis toward dextran and after subdermal injection of histamine by using sharpened glass capillaries (tip diam 5-7 microns) connected to a servo-controlled counterpressure system." | 3.68 | Increased negativity of interstitial fluid pressure during the onset stage of inflammatory edema in rat skin. ( Reed, RK; Rodt, SA, 1991) |
| " Lesions were induced by histamine or by antigen to evoke type I (passive cutaneous anaphylaxis), type III (reverse passive Arthus) and type IV (delayed hypersensitivity) allergic reactions." | 3.66 | Anti-inflammatory drug actions on allergic responses in guinea-pig skin. ( Beets, JL; Bray, MA; Morley, J; Paul, W, 1978) |
| "Histamine prick tests were performed four times at the treatment sites (before treatment, and days 1, 3 and 7 after treatment)." | 2.74 | Botulinum toxin type A reduces histamine-induced itch and vasomotor responses in human skin. ( Arendt-Nielsen, L; Drewes, AM; Gazerani, P; Pedersen, NS, 2009) |
| "25 x 10(-5) M RANTES produced a dose-response stimulation of HDC mRNA in the tissues of skin injection sites." | 1.30 | RANTES is a pro-inflammatory chemokine and chemoattracts basophil cells to extravascular sites. ( Barbacane, RC; Boucher, W; Conti, P; Letourneau, R; Pang, X; Reale, M; Theoharides, TC; Thibault, J, 1997) |
| "For allergic contact hypersensitivity reactions (ACH), the coefficient of variation was significantly less using the scanning LDV." | 1.28 | Measurement of cutaneous inflammatory reactions using a scanning laser-Doppler velocimeter. ( Essex, T; Farr, PM; McLelland, J; Quinn, AG, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 47 (58.02) | 18.7374 |
| 1990's | 17 (20.99) | 18.2507 |
| 2000's | 11 (13.58) | 29.6817 |
| 2010's | 6 (7.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| da Silva, BAF | 1 |
| da Costa, RHS | 1 |
| Fernandes, CN | 1 |
| Leite, LHI | 1 |
| Ribeiro-Filho, J | 1 |
| Garcia, TR | 1 |
| Coutinho, HDM | 1 |
| Wanderley, AG | 1 |
| de Menezes, IRA | 1 |
| Zheng, Y | 1 |
| Che, D | 1 |
| Peng, B | 1 |
| Hao, Y | 1 |
| Zhang, X | 1 |
| He, L | 1 |
| Geng, S | 1 |
| Wechsler, JB | 1 |
| Hsu, CL | 1 |
| Bryce, PJ | 1 |
| Sun, WY | 1 |
| Dimasi, DP | 1 |
| Pitman, MR | 1 |
| Zhuang, Y | 1 |
| Heddle, R | 1 |
| Pitson, SM | 1 |
| Grimbaldeston, MA | 1 |
| Bonder, CS | 1 |
| Gazerani, P | 1 |
| Pedersen, NS | 1 |
| Drewes, AM | 1 |
| Arendt-Nielsen, L | 1 |
| Kim, HJ | 1 |
| Kim, KM | 1 |
| Koh, JY | 1 |
| Noh, MS | 1 |
| Park, MK | 1 |
| Lee, HJ | 1 |
| Kim, SY | 1 |
| Lee, CH | 1 |
| Blunk, JA | 1 |
| Sauerstein, K | 1 |
| Schmelz, M | 1 |
| BENJAMIN, FB | 1 |
| BEERMAN, H | 1 |
| SHELLEY, WB | 1 |
| TORRES-ACERO FERNANDEZ, JM | 1 |
| FISHER, JP | 1 |
| COOKE, RA | 1 |
| CERHOVA, M | 1 |
| SIDLOVA, A | 1 |
| ZELENY, A | 1 |
| GELFAND, HH | 1 |
| CINDER, JC | 1 |
| GRANT, SF | 1 |
| SOIFFER, M | 1 |
| JAQUET, H | 1 |
| JUHLIN, L | 1 |
| GRUPPER, C | 1 |
| HURIEZ, C | 2 |
| DESMONS, F | 2 |
| AGACHE, P | 2 |
| BAELDEN, J | 2 |
| DUQUENNE, JP | 1 |
| VOLKOV, VP | 1 |
| VONGEMMINGEN, GR | 1 |
| WINKELMANN, RK | 1 |
| MARTIN, P | 1 |
| DUQUESNE, JP | 1 |
| ZACHARIAE, H | 2 |
| HARUNA, H | 1 |
| TAKASHIMA, H | 1 |
| KONOSHITA, K | 1 |
| MUTSUBAYASHI, A | 1 |
| KOUNO, M | 1 |
| SCHAPOSCHNIKOW, OK | 1 |
| Kourilová, P | 1 |
| Hogg, KG | 1 |
| Kolárová, L | 1 |
| Mountford, AP | 1 |
| Khalil, Z | 1 |
| Pearce, AL | 1 |
| Satkunanathan, N | 1 |
| Storer, E | 1 |
| Finlay-Jones, JJ | 1 |
| Hart, PH | 1 |
| LEWIS, GM | 1 |
| DAVIS, J | 1 |
| WALDRIFF, GA | 1 |
| BRETT, R | 1 |
| GROTERJAHN, A | 1 |
| ORMEA, F | 1 |
| DURAN CORDOVA, J | 1 |
| CUEVA VELAZQUEZ, J | 1 |
| Gaudy-Marqueste, C | 1 |
| Grob, JJ | 1 |
| Richard, MA | 1 |
| Song, HJ | 1 |
| Hu, JH | 1 |
| Huang, J | 1 |
| Xu, YF | 1 |
| Jing, L | 1 |
| Duart, MJ | 1 |
| García-Domenech, R | 1 |
| Galvez, J | 1 |
| Aleman, PA | 1 |
| Martín-Algarra, RV | 1 |
| Antón-Fos, GM | 1 |
| Corcóstegui, R | 1 |
| Labeaga, L | 1 |
| Innerárity, A | 1 |
| Berisa, A | 1 |
| Orjales, A | 1 |
| Asakawa, M | 1 |
| Yoshioka, T | 1 |
| Matsutani, T | 1 |
| Hikita, I | 1 |
| Suzuki, M | 1 |
| Oshima, I | 1 |
| Tsukahara, K | 1 |
| Arimura, A | 1 |
| Horikawa, T | 1 |
| Hirasawa, T | 1 |
| Sakata, T | 1 |
| OLIVETTI, L | 1 |
| Borelli, S | 1 |
| Chlebarov, S | 1 |
| Woodward, DF | 2 |
| Owen, DA | 2 |
| Mikuni, I | 1 |
| DiSclafani, A | 1 |
| Wilkin, JK | 1 |
| Gilchrest, BA | 1 |
| Stoff, JS | 1 |
| Soter, NA | 2 |
| Medansky, RS | 1 |
| Handler, RM | 1 |
| Wintroub, BU | 1 |
| James, MP | 1 |
| Kennedy, AR | 1 |
| Eady, RA | 1 |
| Johansson, O | 3 |
| Virtanen, M | 1 |
| Hilliges, M | 2 |
| Kjaerheim, V | 1 |
| Barkvoll, P | 1 |
| Waaler, SM | 1 |
| Rölla, G | 1 |
| Björnhagen, V | 1 |
| Hall, K | 1 |
| Hruza, LL | 1 |
| Pentland, AP | 2 |
| Malaviya, R | 1 |
| Morrison, AR | 1 |
| Dux, M | 1 |
| Jancsó, G | 1 |
| Sann, H | 1 |
| Pierau, FK | 1 |
| Oran, A | 1 |
| Marshall, JS | 1 |
| Kondo, S | 1 |
| Paglia, D | 1 |
| McKenzie, RC | 1 |
| Conti, P | 1 |
| Pang, X | 1 |
| Boucher, W | 1 |
| Letourneau, R | 1 |
| Reale, M | 1 |
| Barbacane, RC | 1 |
| Thibault, J | 1 |
| Theoharides, TC | 1 |
| Baluk, P | 1 |
| Hiragun, T | 1 |
| Morita, E | 1 |
| Shindo, H | 1 |
| Tanaka, T | 1 |
| Kameyoshi, Y | 1 |
| Okabe, T | 1 |
| Kanno, M | 1 |
| Yamamoto, S | 1 |
| Yamaguchi, T | 1 |
| Maekawa, T | 1 |
| Nishikawa, Y | 1 |
| Nojima, H | 1 |
| Kaneko, M | 1 |
| Kawakita, T | 1 |
| Miyamoto, T | 1 |
| Kuraishi, Y | 1 |
| Gangi, S | 1 |
| Liang, Y | 1 |
| Yoshimura, K | 1 |
| Jing, C | 1 |
| Liu, PY | 1 |
| Paul, W | 1 |
| Beets, JL | 1 |
| Bray, MA | 1 |
| Morley, J | 1 |
| Filipp, G | 1 |
| Greaves, MW | 2 |
| Kingston, WP | 1 |
| Eaglstein, WH | 1 |
| Weinstein, GD | 1 |
| Hay, JB | 1 |
| Johnston, MG | 1 |
| Hobbs, BB | 1 |
| Movat, HZ | 1 |
| Bavandi, A | 1 |
| Meingassner, JG | 1 |
| Becker, S | 1 |
| Rihoux, JP | 3 |
| Ghys, L | 2 |
| Mühlethaler, K | 1 |
| Wüthrich, B | 1 |
| Foster, AP | 1 |
| Cunningham, FM | 1 |
| Lees, P | 1 |
| Reed, RK | 1 |
| Rodt, SA | 1 |
| Gonzales, R | 1 |
| Coderre, TJ | 1 |
| Sherbourne, CD | 1 |
| Levine, JD | 1 |
| Quinn, AG | 1 |
| McLelland, J | 1 |
| Essex, T | 1 |
| Farr, PM | 1 |
| Humphreys, F | 1 |
| Shuster, S | 1 |
| Katsunuma, T | 1 |
| Iikura, Y | 1 |
| Nagakura, T | 1 |
| Saitoh, H | 1 |
| Akimoto, K | 1 |
| Akasawa, A | 1 |
| Kindaichi, S | 1 |
| Van Neste, D | 2 |
| Antoine, JL | 1 |
| Haustein, UF | 1 |
| Kunz, C | 1 |
| Ichikawa, A | 1 |
| Hayashi, H | 1 |
| Minami, M | 1 |
| Tomita, K | 1 |
| Kamimura, M | 1 |
| Sato, N | 1 |
| Himuro, I | 1 |
| Shioya, A | 1 |
| Baumgarten, A | 1 |
| Melrose, GJ | 1 |
| Vagg, WJ | 1 |
| Takeda, K | 1 |
| Shigemi, F | 1 |
| Arakawa, T | 1 |
| Nozicková, M | 1 |
| Holzmann, H | 1 |
| Lachner, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Itch Relieving Effect of Botox: a Study in Healthy Subjects[NCT02639052] | Phase 1/Phase 2 | 35 participants (Actual) | Interventional | 2016-02-29 | Completed | ||
| The Use of Botulinum Toxin in the Treatment of Itching From Hypertrophic Scar -- A Randomised Controlled Trial[NCT02168634] | 60 participants (Anticipated) | Interventional | 2013-11-30 | Recruiting | |||
| Effect of Camel Milk Containing Bifidobacterium Animalis A6 on Chinese People With Type 2 Diabetes Mellitus[NCT04296825] | Phase 1 | 45 participants (Actual) | Interventional | 2018-06-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
A secondary endpoint is to see if Botox has a relieving effect on heat pain using a pain visual analog scale (VAS) intensity scale as an outcome measure. The pain VAS intensity scale ranges from a minimum of 0 (no pain - best) to a maximum of 10 (maximum pain - worst). Participants will rate pain intensity after pain is induced with a heat thermode. (NCT02639052)
Timeframe: Baseline, 1 week, 1 month, 3 months
| Intervention | units on a scale (Mean) | ||||
|---|---|---|---|---|---|
| Baseline | 1 Week | 1 Month | 3 Months | All Visits | |
| Botox | 3.6 | 3.7 | 3.7 | 4.1 | 3.8 |
| Saline | 3.7 | 3.7 | 4.1 | 4.3 | 4.0 |
The primary endpoint is to test the antipruritic effect of Botox using an itch visual analog scale (VAS) intensity scale as an outcome measure. The itch VAS intensity scale ranges from a minimum of 0 (no itch - best) to a maximum of 10 (maximum itch - worst). Participants will rate itch intensity after itch is induced with cowhage. (NCT02639052)
Timeframe: 1 Month from Baseline
| Intervention | units on a scale (Mean) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Month (Visit 3), 0 seconds | 1 Month (Visit 3), 30 seconds | 1 Month (Visit 3), 60 seconds | 1 Month (Visit 3), 90 seconds | 1 Month (Visit 3), 120 seconds | 1 Month (Visit 3), 150 seconds | 1 Month (Visit 3), 180 seconds | 1 Month (Visit 3), 210 seconds | 1 Month (Visit 3), 240 seconds | 1 Month (Visit 3), 270 seconds | 1 Month (Visit 3), 300 seconds | 1 Month (Visit 3), All Times | |
| Botox | 3.2 | 5.0 | 5.1 | 4.3 | 3.5 | 2.3 | 1.5 | 0.9 | 0.7 | 0.3 | 0.2 | 2.5 |
| Saline | 3.8 | 6.2 | 6.2 | 5.7 | 4.5 | 3.3 | 2.2 | 1.4 | 0.9 | 0.6 | 0.4 | 3.2 |
The primary endpoint is to test the antipruritic effect of Botox using an itch visual analog scale (VAS) intensity scale as an outcome measure. The itch VAS intensity scale ranges from a minimum of 0 (no itch - best) to a maximum of 10 (maximum itch - worst). Participants will rate itch intensity after itch is induced with cowhage. (NCT02639052)
Timeframe: 1 week from Baseline
| Intervention | units on a scale (Mean) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Week (Visit 2), 0 seconds | 1 Week (Visit 2), 30 seconds | 1 Week (Visit 2), 60 seconds | 1 Week (Visit 2), 90 seconds | 1 Week (Visit 2), 120 seconds | 1 Week (Visit 2), 150 seconds | 1 Week (Visit 2), 180 seconds | 1 Week (Visit 2), 210 seconds | 1 Week (Visit 2), 240 seconds | 1 Week (Visit 2), 270 seconds | 1 Week (Visit 2), 300 seconds | 1 Week (Visit 2), All Times | |
| Botox | 3.3 | 5.4 | 5.9 | 4.9 | 3.7 | 2.7 | 2.0 | 1.4 | 0.9 | 0.6 | 0.4 | 2.8 |
| Saline | 4.0 | 6.7 | 6.9 | 6.1 | 4.8 | 3.8 | 2.7 | 1.9 | 1.3 | 0.9 | 0.7 | 3.6 |
The primary endpoint is to test the antipruritic effect of Botox using an itch visual analog scale (VAS) intensity scale as an outcome measure. The itch VAS intensity scale ranges from a minimum of 0 (no itch - best) to a maximum of 10 (maximum itch - worst). Participants will rate itch intensity after itch is induced with cowhage. (NCT02639052)
Timeframe: 3 Months from Baseline
| Intervention | units on a scale (Mean) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Months (Visit 4), 0 seconds | 3 Months (Visit 4), 30 seconds | 3 Months (Visit 4), 60 seconds | 3 Months (Visit 4), 90 seconds | 3 Months (Visit 4), 120 seconds | 3 Months (Visit 4), 150 seconds | 3 Months (Visit 4), 180 seconds | 3 Months (Visit 4), 210 seconds | 3 Months (Visit 4), 240 seconds | 3 Months (Visit 4), 270 seconds | 3 Months (Visit 4), 300 seconds | 3 Months (Visit 4), All Times | |
| Botox | 2.3 | 4.5 | 4.9 | 4.6 | 3.8 | 3.0 | 2.1 | 1.5 | 1.0 | 0.7 | 0.3 | 2.6 |
| Saline | 3.3 | 5.4 | 5.9 | 5.2 | 4.7 | 3.6 | 2.8 | 1.9 | 1.4 | 0.9 | 0.6 | 3.2 |
The primary endpoint is to test the antipruritic effect of Botox using an itch visual analog scale (VAS) intensity scale as an outcome measure. The itch VAS intensity scale ranges from a minimum of 0 (no itch - best) to a maximum of 10 (maximum itch - worst). Participants will rate itch intensity after itch is induced with cowhage. (NCT02639052)
Timeframe: Baseline (Visit 1)
| Intervention | units on a scale (Mean) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline (Visit 1), 0 seconds | Baseline (Visit 1), 30 seconds | Baseline (Visit 1), 60 seconds | Baseline (Visit 1), 90 seconds | Baseline (Visit 1), 120 seconds | Baseline (Visit 1), 150 seconds | Baseline (Visit 1), 180 seconds | Baseline (Visit 1), 210 seconds | Baseline (Visit 1), 240 seconds | Baseline (Visit 1), 270 seconds | Baseline (Visit 1), 300 seconds | Baseline (Visit 1), All Times | |
| Botox | 4.5 | 6.5 | 6.8 | 5.9 | 5.1 | 4.1 | 2.8 | 2.0 | 1.3 | 0.9 | 0.6 | 3.7 |
| Saline | 4.3 | 6.3 | 6.5 | 6.3 | 5.1 | 3.9 | 2.8 | 2.0 | 1.4 | 0.9 | 0.9 | 3.7 |
7 reviews available for histamine and Dermatitis
| Article | Year |
|---|---|
[Anti-H1 in dermatological practice].
Topics: Dermatitis; Histamine; Histamine H1 Antagonists; Humans; Inflammation; Urticaria | 2005 |
Eye itching in ophthalmology and its treatment.
Topics: Conjunctiva; Cromolyn Sodium; Dermatitis; Eczema; Edema; Emotions; Eye; Histamine; Histamine H1 Anta | 1984 |
Dermatopsychosomatics: classification, physiology, and therapeutic approaches.
Topics: Anxiety; Delusions; Dermatitis; Eczema; Factitious Disorders; Histamine; Humans; Neurotic Disorders; | 1981 |
Biology of the mast cell and its role in cutaneous inflammation.
Topics: Animals; Bone Marrow Cells; Chemotactic Factors; Chemotactic Factors, Eosinophil; Cytoplasmic Granul | 1981 |
Mechanisms of UV-induced inflammation.
Topics: Dermatitis; Epidermis; Histamine; Humans; Lipid Peroxides; Photochemistry; Prostaglandins; Radiation | 1993 |
Neurogenic inflammation in skin and airways.
Topics: Animals; Dermatitis; Histamine; Humans; Inflammation Mediators; Mast Cells; Neurons, Afferent; Perip | 1997 |
Inflammation and mediators.
Topics: Dermatitis; Histamine; Humans; Inflammation; Mast Cells | 1988 |
6 trials available for histamine and Dermatitis
| Article | Year |
|---|---|
Botulinum toxin type A reduces histamine-induced itch and vasomotor responses in human skin.
Topics: Adult; Antipruritics; Botulinum Toxins, Type A; Dermatitis; Double-Blind Method; Histamine; Humans; | 2009 |
Botulinum toxin type A reduces histamine-induced itch and vasomotor responses in human skin.
Topics: Adult; Antipruritics; Botulinum Toxins, Type A; Dermatitis; Double-Blind Method; Histamine; Humans; | 2009 |
Botulinum toxin type A reduces histamine-induced itch and vasomotor responses in human skin.
Topics: Adult; Antipruritics; Botulinum Toxins, Type A; Dermatitis; Double-Blind Method; Histamine; Humans; | 2009 |
Botulinum toxin type A reduces histamine-induced itch and vasomotor responses in human skin.
Topics: Adult; Antipruritics; Botulinum Toxins, Type A; Dermatitis; Double-Blind Method; Histamine; Humans; | 2009 |
Regulation of wheal and flare by tea tree oil: complementary human and rodent studies.
Topics: Animals; Animals, Outbred Strains; Anti-Inflammatory Agents; Cyclohexane Monoterpenes; Cyclohexanols | 2004 |
Triclosan inhibits histamine-induced inflammation in human skin.
Topics: Administration, Cutaneous; Adult; Anti-Infective Agents, Local; Anti-Inflammatory Agents, Non-Steroi | 1995 |
The skin as a target organ for the investigation of antiallergic drugs: comparison between cetirizine and terfenadine.
Topics: Adolescent; Adult; Antigens; Cetirizine; Dermatitis; Double-Blind Method; Female; Histamine; Histami | 1992 |
Pharmacological modulation by cetirizine and atropine of the histamine- and methacholine-induced wheals and flares in human skin.
Topics: Adult; Atropine; Cetirizine; Dermatitis; Double-Blind Method; Female; Galvanic Skin Response; Histam | 1989 |
Inhibition of the cutaneous response to histamine by H1-blocking agents. Quantitative evaluation of microvascular changes in the skin after histamine challenge and a comparison of the effects of a single intake of cetirizine and terfenadine.
Topics: Adult; Benzhydryl Compounds; Cetirizine; Dermatitis; Double-Blind Method; Erythema; Female; Histamin | 1988 |
68 other studies available for histamine and Dermatitis
| Article | Year |
|---|---|
HPLC profile and antiedematogenic activity of Ximenia americana L. (Olacaceae) in mice models of skin inflammation.
Topics: Animals; Arachidonic Acid; Capsaicin; Chromatography, High Pressure Liquid; Croton Oil; Dermatitis; | 2018 |
All-trans-retinoic acid activated mast cells via Mas-related G-protein-coupled receptor-X2 in retinoid dermatitis.
Topics: Animals; beta-N-Acetylhexosaminidases; Calcium; Cell Degranulation; Cell Line; Dermatitis; Dermatiti | 2019 |
IgE-mediated mast cell responses are inhibited by thymol-mediated, activation-induced cell death in skin inflammation.
Topics: Anaphylaxis; Animals; Apoptosis; Calcium; Cell Death; Cell Degranulation; Cell Survival; Dermatitis; | 2014 |
Topical Application of Fingolimod Perturbs Cutaneous Inflammation.
Topics: Administration, Topical; Animals; Capillary Permeability; Cell Movement; Cells, Cultured; Cytokines; | 2016 |
Sphingosylphosphorylcholine induces degranulation of mast cells in the skin and plasma exudation in the ears of mice.
Topics: Animals; Dermatitis; Dose-Response Relationship, Drug; Ear; Histamine; Inflammation; Mast Cells; Mic | 2010 |
Experimental thermal lesions induce beta-thromboglobulin release from activated platelets.
Topics: Administration, Cutaneous; Adult; beta-Thromboglobulin; Blood Platelets; Dermatitis; Female; Histami | 2011 |
Allergic contact dermatitis due to histamine-releasing drug 48-80.
Topics: Dermatitis; Dermatitis, Allergic Contact; Dermatitis, Contact; Histamine; Humans | 1955 |
[Clinical results obtained with a new synthetic histamine: methylaminophenylthienylpiperidine tartrate (sandostene)].
Topics: Asthma; Calcium; Dermatitis; Dermatitis, Contact; Histamine; Histamine H1 Antagonists; Tartrates | 1957 |
Experimental toxic and allergic contact dermatitis. I. A chemical study of histamine content.
Topics: Dermatitis; Dermatitis, Allergic Contact; Dermatitis, Contact; Histamine; Humans | 1958 |
The effect of skin inflammation on blood content of serotonin and histamine.
Topics: Dermatitis; Histamine; Humans; Inflammation; Serotonin; Ultraviolet Rays | 1962 |
Evaluation of histamine-gamma globulin (histaglobin) in the treatment of various allergic conditions.
Topics: Dermatitis; Dermatitis, Atopic; Drug Combinations; gamma-Globulins; Histamine; Humans; Respiratory H | 1963 |
[ATTEMPT AT AN INTERPRETATION OF THE MECHANISM OF ACTION OF THE INFLAMMATORY SKIN REACTION CAUSED BY LIBERATION PROCESSES].
Topics: Anaphylaxis; Bradykinin; Dermatitis; Edema; Histamine; Histamine Release; Inflammation; p-Methoxy-N- | 1963 |
REACTIONS TO INFUSION OF A HISTAMINE LIBERATOR. EFFECTS OF COMPOUND 48/80 ON EOSINOPHIL AND BASOPHIL LEUKOCYTES IN PATIENTS WITH ATOPIC DERMATITIS, URTICARIA, AND ALOPECIA AREATA.
Topics: Alopecia Areata; Basophils; Blood Cell Count; Dermatitis; Dermatitis, Atopic; Eczema; Eosinophils; H | 1963 |
[PROTECTIVE SERUMS AND GAMMA GLOBULINS IN DERMATOLOGY].
Topics: Acne Vulgaris; Chickenpox; Dermatitis; Dermatitis, Atopic; Dermatology; Eczema; gamma-Globulins; Her | 1963 |
[THE MIKOL-RENOUX-MERKLEN LATEX-HISTAMINE REACTION IN DERMATOLOGY, AS BASED ON 1,000 DETERMINATIONS].
Topics: Dermatitis; Dermatitis, Contact; Dermatology; Eczema; Histamine; Humans; Hypersensitivity; Latex; La | 1964 |
[THE CONTENT OF CERTAIN METABOLITES IN THE BLOOD AND URINE OF HEALTHY PERSONS AND DERMATOSIS PATIENTS].
Topics: Acetylcholine; Blood Chemical Analysis; Dermatitis; Dermatitis, Seborrheic; Eczema; Erythema Multifo | 1963 |
ZOSTER IN A PATIENT WITH ATOPIC DERMATITIS.
Topics: Cortisone; Dermatitis; Dermatitis, Atopic; Eczema; Herpes Zoster; Histamine; Humans; Methacholine Co | 1964 |
[USEFULNESS IN DERMATO-ALLERGOLOGY OF THE LATEX-HISTAMINE TEST (1004 TESTS) AND OF MEASUREMENT OF THE HISTAMINOPEXIC CAPACITY OF THE SERUM (3088 DETERMINATIONS)].
Topics: Blood Proteins; Dermatitis; Dermatitis Herpetiformis; Dermatitis, Contact; Dermatology; Dermatomycos | 1964 |
HISTAMINE IN DELAYED SKIN REACTIONS. FLUOROMETRIC DETERMINATIONS ON PATCH TESTS.
Topics: Dermatitis; Dermatitis, Contact; Fluorometry; Fluoroscopy; Histamine; Histamine Release; Histology; | 1964 |
STUDIES ON ASTHMATIC CHILDREN.
Topics: Adolescent; Asthma; Blood; Child; Dermatitis; Dermatitis, Atopic; Dexamethasone; Drug Hypersensitivi | 1964 |
SKIN HISTAMINE AND DELAYED SKIN REACTIONS. FLUOROMETRIC DETERMINATIONS ON PATCH TESTS.
Topics: Dermatitis; Dermatitis, Contact; Fluorescence; Fluorometry; Histamine; Humans; Patch Tests; Skin Tes | 1964 |
[On the role of histamine and histamine-like substances in the mechanism of disorder of permeability of the skin blood vessels in the formation of bullous elements].
Topics: Dermatitis; Histamine; Humans; Permeability; Skin | 1960 |
Cercarial dermatitis caused by bird schistosomes comprises both immediate and late phase cutaneous hypersensitivity reactions.
Topics: Animals; Bird Diseases; Cell Degranulation; Cytokines; Dermatitis; Ducks; Female; Histamine; Hyperse | 2004 |
Antihistamine therapy in dermatology.
Topics: Dermatitis; Dermatology; Histamine; Histamine H1 Antagonists; Humans | 1950 |
[Optimal antihistamine therapy in dermatology, with a contribution concerning a new antihistamine, avil].
Topics: Anti-Allergic Agents; Dermatitis; Dermatology; Histamine; Histamine H1 Antagonists; Humans; Pheniram | 1950 |
[Synopen, a new antihistamine preparation].
Topics: Anti-Allergic Agents; Dermatitis; Histamine; Histamine H1 Antagonists; Humans | 1950 |
[Synthetic antihistamines in dermatology].
Topics: Anaphylaxis; Dermatitis; Dermatology; Histamine; Histamine Antagonists; Humans; Hypersensitivity | 1950 |
[Local antihistamines in contact dermatitis].
Topics: Anti-Allergic Agents; Dermatitis; Dermatitis, Contact; Histamine; Histamine Antagonists; Humans | 1950 |
[Intervention of cetirizine on monocyte chemoattractant protein-1 in cutaneous inflammation].
Topics: Cell Line; Cells, Cultured; Cetirizine; Chemokine CCL2; Dermatitis; Dermis; Fibroblasts; Histamine; | 2005 |
Application of a mathematical topological pattern of antihistaminic activity for the selection of new drug candidates and pharmacology assays.
Topics: Aniline Compounds; Animals; Anthracenes; Benzothiazoles; Databases, Factual; Dermatitis; Drug Design | 2006 |
In vivo pharmacological characterisation of bilastine, a potent and selective histamine H1 receptor antagonist.
Topics: Animals; Benzimidazoles; Bradykinin; Bronchial Spasm; Capillary Permeability; Cetirizine; Dermatitis | 2006 |
Association of a mutation in TRPV3 with defective hair growth in rodents.
Topics: Alopecia; Amino Acid Substitution; Animals; Cell Count; Cloning, Molecular; Cysteine; Dermatitis; El | 2006 |
Influence of synthetic antihistamines on the formation of antibodies in allergic dermatoses.
Topics: Dermatitis; Histamine; Histamine Antagonists; Humans | 1949 |
[Changes in the histamine reactivity of the skin after Alpine climatic treatment].
Topics: Adult; Altitude; Climate; Dermatitis; Dermatitis, Atopic; Eczema; Female; Health Resorts; Histamine; | 1966 |
Effect of H1-and H2-receptor antagonists on cutaneous inflammation evoked by histamine analogues and UV radiation.
Topics: Animals; Body Temperature; Cimetidine; Dermatitis; Guinea Pigs; Histamine; Histamine H1 Antagonists; | 1982 |
The axon reflex flare.
Topics: Adenosine Triphosphate; Axons; Dermatitis; Histamine; Humans; Kinins; Neural Conduction; Prostagland | 1983 |
Studies on histamine-induced cutaneous flare in the guinea pig.
Topics: Anesthetics, Local; Animals; Blood Vessels; Capillary Permeability; Dermatitis; Guinea Pigs; Histami | 1983 |
Chronologic aging alters the response to ultraviolet-induced inflammation in human skin.
Topics: Adult; Aged; Aging; Dermatitis; Dinoprostone; Female; Histamine; Humans; Male; Prostaglandins E; Ski | 1982 |
A microscopic study of inflammatory reactions in human skin induced by histamine and compound 48/80.
Topics: Adolescent; Adult; Aged; Dermatitis; Histamine; Humans; Injections, Intradermal; Leukocytes; Mast Ce | 1982 |
Histaminergic nerves demonstrated in the skin. A new direct mode of neurogenic inflammation?
Topics: Animals; Dermatitis; Feedback; Histamine; Histamine Release; Intradermal Tests; Male; Mast Cells; Mi | 1995 |
Skin changes in patients claiming to suffer from "screen dermatitis": a two-case open-field provocation study.
Topics: Adult; Computer Terminals; Dermatitis; Female; Histamine; Humans; Immunohistochemistry; Middle Aged; | 1994 |
Histamine in human epidermal cells is induced by ultraviolet light injury.
Topics: Adult; Cells, Cultured; Dermatitis; Histamine; Histamine Release; Humans; Keratinocytes; Ultraviolet | 1996 |
Inhibition of the neurogenic inflammatory response by lidocaine in rat skin.
Topics: Anesthetics, Local; Animals; Coloring Agents; Dermatitis; Evans Blue; Histamine; Lidocaine; Male; Mu | 1996 |
Cyclosporin inhibits intercellular adhesion molecule-1 expression and reduces mast cell numbers in the asebia mouse model of chronic skin inflammation.
Topics: Animals; Cell Count; Cyclosporine; Dermatitis; Disease Models, Animal; Gene Expression; Histamine; I | 1997 |
RANTES is a pro-inflammatory chemokine and chemoattracts basophil cells to extravascular sites.
Topics: Animals; Basophils; Blotting, Northern; Chemokine CCL5; Chemotaxis, Leukocyte; Dermatitis; Dose-Resp | 1997 |
Altered in vitro apoptosis of cultured mast cells prepared from an inbred strain of mice, NC/Kuj.
Topics: Animals; Apoptosis; Bone Marrow Cells; Cell Adhesion; Cell Survival; Cells, Cultured; Dermatitis; Hi | 2000 |
Characterization of itch-associated responses of NC mice with mite-induced chronic dermatitis.
Topics: Animals; Attention; Chronic Disease; Dermatitis; Female; Histamine; Immunoglobulin E; Mice; Mice, In | 2001 |
Cutaneous mast cells are altered in normal healthy volunteers sitting in front of ordinary TVs/PCs--results from open-field provocation experiments.
Topics: Adult; Biopsy; Computer Terminals; Data Display; Dermatitis; Dermis; Electromagnetic Fields; Female; | 2001 |
Anti-inflammatory drug actions on allergic responses in guinea-pig skin.
Topics: Animals; Anti-Inflammatory Agents; Arthus Reaction; Autacoids; Capillary Permeability; Dermatitis; G | 1978 |
[Clinical experiences with histamine-azoprotein and serotonine-azo-protein in the therapy of allergic diseases (author's transl)].
Topics: Asthma; Azo Compounds; Dermatitis; Dermatitis, Atopic; Dermatitis, Contact; gamma-Globulins; Haptens | 1977 |
Prostaglandins as mediators of sustained inflammation in the skin.
Topics: Animals; Anura; Dermatitis; Drug Synergism; Erythema; Histamine; Humans; Prostaglandin Antagonists; | 1975 |
Prostaglandin and DNA synthesis in human skin: possible relationship to ultraviolet light effects.
Topics: Aged; Chromatography, Thin Layer; Dermatitis; DNA; Dose-Response Relationship, Drug; Female; Histami | 1975 |
The use of radioactive microspheres to quantitate hyperemia in dermal inflammatory sites.
Topics: Animals; Bradykinin; Dermatitis; Female; Guinea Pigs; Histamine; Hyperemia; Lymphocyte Transfusion; | 1975 |
Diet-induced dermatitis response of hairless rats to systemic treatment with cyclosporin A (Sandimmun), cyclosporin H and FK506.
Topics: Animals; Cyclosporine; Dermatitis; Diet; Dose-Response Relationship, Drug; Hair; Histamine; Leukocyt | 1992 |
Inflammatory effects of platelet activating factor (PAF) in equine skin.
Topics: Animals; Capillary Permeability; Chlorpheniramine; Dermatitis; Dinoprostone; Dose-Response Relations | 1992 |
Increased negativity of interstitial fluid pressure during the onset stage of inflammatory edema in rat skin.
Topics: Anaphylaxis; Animals; Capillary Permeability; Cyproheptadine; Dermatitis; Dextrans; Edema; Female; H | 1991 |
Postnatal development of neurogenic inflammation in the rat.
Topics: Aging; Animals; Animals, Newborn; Bradykinin; Dermatitis; Histamine; Injections, Intradermal; Nervou | 1991 |
Measurement of cutaneous inflammatory reactions using a scanning laser-Doppler velocimeter.
Topics: Dermatitis; Dermatitis, Atopic; Dermatitis, Contact; Dose-Response Relationship, Drug; Dose-Response | 1991 |
The effect of indomethacin on the kinetics of histamine, 48/80 and antigen wealing.
Topics: Adult; Animals; Cyclooxygenase Inhibitors; Dermatitis; Dose-Response Relationship, Drug; Female; Hal | 1990 |
Exercise-induced anaphylaxis: improvement after removal of amalgam in dental caries.
Topics: Anaphylaxis; Asthma, Exercise-Induced; Child; Dental Amalgam; Dermatitis; Drug Hypersensitivity; Exe | 1990 |
[Histamine reactivity of affected and unaffected skin in endogenous eczema and in chronic allergic contact dermatitis].
Topics: Dermatitis; Dermatitis, Contact; Eczema; Histamine; Humans; Skin; T-Lymphocytes | 1986 |
An acute inflammation induced by inorganic pyrophosphate and adenosine triphosphate, and its inhibition by cyclic 3',5'-adenosine monophosphate.
Topics: Acute Disease; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Cell Membrane Permeability; | 1972 |
Antiinflammatory activity of vitamin E.
Topics: Acetylcholine; Administration, Topical; Animals; Anti-Inflammatory Agents; Dermatitis; Dextrans; Ede | 1972 |
A photoelectric method for estimating inflammatory intensity in mice and its application to the anti-inflammatory evaluation of glucuronic acid derivatives.
Topics: Acetates; Aminopyrine; Animals; Calcium Chloride; Coloring Agents; Dermatitis; Dextrans; Drug Synerg | 1967 |
Continuous recording of dermal exudative reactions.
Topics: Aniline Compounds; Animals; Blood Proteins; Dermatitis; Exudates and Transudates; Guinea Pigs; Hista | 1970 |
[Intradermal reaction of bradykinin, serotonin and histamine].
Topics: Bradykinin; Dermatitis; Female; Histamine; Humans; Male; Serotonin; Skin Tests; Urticaria | 1967 |
[Determination of the antihistaminic factor of the serum with the method of latex-histamine test].
Topics: Dermatitis; Dermatitis, Atopic; Histamine; Humans; Hypersensitivity; Latex; Methods; Microspheres; U | 1969 |
[Value of human pharmacology test methods in the comparative assessment of topical corticosteroids].
Topics: Betamethasone; Dermatitis; Flumethasone; Fluocinolone Acetonide; Glucocorticoids; Histamine; Humans; | 1969 |